MUZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 9.157
EU - Europa 1.989
AS - Asia 841
SA - Sud America 101
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 13
OC - Oceania 4
Totale 12.152
Nazione #
US - Stati Uniti d'America 9.111
IT - Italia 1.078
SG - Singapore 358
CN - Cina 208
DE - Germania 182
FR - Francia 136
UA - Ucraina 121
RU - Federazione Russa 111
BR - Brasile 78
VN - Vietnam 78
NL - Olanda 67
IE - Irlanda 62
HK - Hong Kong 60
SE - Svezia 53
GB - Regno Unito 43
FI - Finlandia 42
PL - Polonia 41
BD - Bangladesh 25
JP - Giappone 25
KR - Corea 25
CZ - Repubblica Ceca 21
CA - Canada 18
IN - India 12
AR - Argentina 10
MX - Messico 10
ID - Indonesia 8
ES - Italia 7
TR - Turchia 6
SV - El Salvador 5
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
NI - Nicaragua 4
PH - Filippine 4
VE - Venezuela 4
AT - Austria 3
CO - Colombia 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
PK - Pakistan 3
PR - Porto Rico 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AL - Albania 2
BG - Bulgaria 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
NG - Nigeria 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TG - Togo 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 12.106
Città #
Woodbridge 2.644
Houston 2.107
Wilmington 1.937
Ann Arbor 244
Ashburn 236
Singapore 228
Chandler 226
Fairfield 219
San Jose 110
Rome 108
Jacksonville 104
Seattle 84
New York 79
Beijing 74
Milan 74
Cambridge 65
Dublin 61
Hong Kong 58
Medford 51
Council Bluffs 49
Dallas 44
Santa Clara 42
The Dalles 34
Los Angeles 32
Kraków 30
Dearborn 28
Ho Chi Minh City 24
Lawrence 24
Naples 21
Prague 21
Tokyo 19
Helsinki 18
Mülheim 18
Buffalo 15
Catania 14
Denver 14
Turin 14
Zhengzhou 14
Florence 13
Hanoi 13
Palo Alto 13
Boardman 12
Falls Church 12
Guangzhou 12
Shanghai 12
Menlo Park 11
Moscow 10
San Diego 10
Columbus 9
Pisa 9
São Paulo 9
Verona 9
Bologna 8
Chicago 8
Civitavecchia 8
Hefei 8
Atlanta 7
Bari 7
London 7
Pioppi 7
University Park 7
Brescia 6
Mountain View 6
Napoli 6
Pavia 6
Toronto 6
Da Nang 5
Lauterbourg 5
Orem 5
Phoenix 5
Reggio Emilia 5
San Mateo 5
Calusco d'Adda 4
Jakarta 4
Managua 4
Montreal 4
Nanjing 4
North Bergen 4
Novara 4
Nuremberg 4
Padova 4
Palermo 4
Redwood City 4
Saint Petersburg 4
Salt Lake City 4
San Salvador 4
Tashkent 4
Treviso 4
Warsaw 4
Altopascio 3
Boston 3
Brasília 3
Cagliari 3
Chennai 3
Curitiba 3
Dong Ket 3
Ercolano 3
Ferrara 3
Fidenza 3
Genoa 3
Totale 9.566
Nome #
Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I 1.618
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 557
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 512
A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells 498
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide 495
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity 490
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma 476
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma 471
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells 470
Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. 469
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies 467
Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine. 453
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. 451
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. 451
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 443
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells 435
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. 430
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. 430
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB 422
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant 418
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. 414
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors 411
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. 409
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. 393
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 69
Totale 12.152
Categoria #
all - tutte 25.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 0 0 0 5 32 6 8 45 36 6 82
2022/2023582 50 50 27 78 38 92 26 41 72 26 43 39
2023/2024449 43 22 38 44 30 87 36 25 18 22 32 52
2024/2025772 44 145 91 63 53 72 45 53 70 38 43 55
2025/20261.154 127 47 139 61 83 49 154 152 143 97 46 56
2026/2027467 69 60 224 112 2 0 0 0 0 0 0 0
Totale 12.152